China Universal Asset Management Company’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
8,438
+740
| +10% | +$30K | 0.03% | 275 |
|
|
2025
Q1 | $395K | Sell |
7,698
-408
| -5% | -$21K | 0.04% | 264 |
|
|
2024
Q4 | $449K | Buy |
8,106
+789
| +11% | +$43.7K | 0.04% | 260 |
|
|
2024
Q3 | $241K | Buy |
7,317
+2,879
| +65% | +$94.7K | 0.03% | 283 |
|
|
2024
Q2 | $121K | Sell |
4,438
-2,129
| -32% | -$57.9K | 0.02% | 290 |
|
|
2024
Q1 | $239K | Buy |
6,567
+2,735
| +71% | +$99.4K | 0.03% | 271 |
|
|
2023
Q4 | $77.6K | Buy |
3,832
+3,004
| +363% | +$60.8K | 0.02% | 315 |
|
|
2023
Q3 | $14.7K | Buy |
828
+476
| +135% | +$8.46K | ﹤0.01% | 319 |
|
|
2023
Q2 | $6.36K | Sell |
352
-10
| -3% | -$181 | ﹤0.01% | 347 |
|
|
2023
Q1 | $4.55K | Buy |
362
+91
| +34% | +$1.14K | ﹤0.01% | 373 |
|
|
2022
Q4 | $3.97K | Buy |
+271
| New | +$3.97K | ﹤0.01% | 321 |
|